First Edition: Friday, May 8, 2026
Today's early morning highlights from the major news organizations.
Archives: Morning Breakouts
221 - 240 of 112,390 Results
-
-
Viewpoints: Maternity Deserts Are Failing US Families; Are Abortion Pill Reversal Claims Free Speech Or Medical Misinformation?
Editorial writers delve into these public health issues.
By khnelysiag -
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
Each week, KFF Health News compiles a selection of health policy studies and briefs.
By khnlaureno -
Georgia Knew About PFAS In Water Near Carpet Mills But Didn’t Warn Residents, Investigation Finds
People who live in and around Calhoun, Georgia, say the levels of "forever chemicals" in their bodies are higher than what national health guidelines consider safe. Some have been diagnosed with liver and thyroid conditions or cancer. Scientists have warned for decades about the risks, but Georgia’s Environmental Protection Division did little to confront the problem, The Atlanta Journal-Constitution, AP, and FRONTLINE (PBS) found.
By khnlaureno -
California Hospital Sees Several Cases Of Legionella, As Search For Source Continues
The Santa Clara Medical Center and medical office building are operating normally as additional water treatment measures are implemented. More news is on potential hospital closures in Minnesota and Pennsylvania; AI integration into healthcare; and more.
By khnlaureno -
Many Kids Hurt By Tear Gas, Pepper Spray During ICE Raids: Report
ProPublica reports on how officers have escalated the use of the chemicals throughout recent anti-immigration initiatives, causing harm to at least 79 children across the country in the process. The Department of Homeland Security says parents are to blame for any harm caused.
By khnlaureno -
Mounjaro Topples Keytruda As The World’s Best-Selling Medication
Eli Lilly's diabetes drug Mounjaro brought in nearly $9 billion in the first quarter of 2026, surpassing the nearly $8 billion in sales for Merck's Keytruda, a cancer therapy.
By khnlaureno -
New ALS Drug Shows Promise In Helping Some Patients Improve
Tofersen targets a small subset of patients with a specific genetic form of amyotrophic lateral sclerosis, also called Lou Gehrig’s disease. The New York Times reports that new study results— in which some patients improved and others did not get worse — are generating hope for the usually fatal disease.
By khnlaureno -
Cruise Passengers From 3 States Monitored For Hantavirus Exposure
As of Wednesday, at least three states — Georgia, California, and Arizona — are monitoring residents who previously disembarked from the MV Hondius cruise ship. At this time, none of the former passengers are showing signs of illness.
By khnlaureno -
First Edition: Thursday, May 7, 2026
Today's early morning highlights from the major news organizations.
By khnlaureno -
-
Viewpoints: Is It Ethical For Young Kids To Take GLP-1s?; AI In Medicine Is A Tool, Not A Replacement
Opinion writers tackle these public health issues.
By khnelysiag -
EpiPen Makers Agree To $4.5M Deal With Maryland Over Its Pricing, Marketing
The settlement comes after the makers were accused of using a monopoly to increase prices, requiring injectors to be purchased in a two-pack, and restricting generic versions of the EpiPen.
By khnlaureno -
AI Deepfakes Are Using Doctors’ Likenesses To Promote Dubious Products, Misinformation
Physicians are calling for stricter laws governing AI in the wake of a slew of deepfake videos circulating on social media. Doctors worry that it could contribute to the ongoing erosion of public trust in the medical establishment, and even to insurance fraud, Axios reports.
By khnlaureno -
2 Cruise Ship Hantavirus Victims Had ‘Andes’ Strain That Spreads From Person To Person
Health officials in South Africa confirmed the findings. Meanwhile, a battle over where to dock the MV Hondius continued Wednesday morning.
By khnlaureno -
While Courts Hash Out Mifepristone Case, Providers Eye Misoprostol For Abortion Care
If the Supreme Court rules that mifepristone can't be prescribed via telehealth or dispensed by mail, providers say, misoprostol alone has been found to be a safe and effective method for ending pregnancies. Some countries already rely on misoprostol for abortion care.
By khnlaureno -
FDA OKs First Fruit-Flavored Vapes For Adults 21 And Older
The move marks a shift after years of efforts by the FDA to regulate flavored vapes and just after The Wall Street Journal reported that President Donald Trump pushed for the approval, The Washington Post reports.
By khnlaureno -
Feds Kept Favorable Studies On Covid, Shingles Vaccines Under Wraps, HHS Confirms
Scientists combed millions of patient records and determined that serious side effects from the covid and shingles shots are rare. The Trump administration withdrew the publication of those studies. Although HHS said "the authors drew broad conclusions that were not supported by the underlying data," career scientists who reviewed the drafts say the studies were well done.
By khnlaureno -
First Edition: Wednesday, May 6, 2026
Today's early morning highlights from the major news organizations.
By khnlaureno -
Viewpoints: Mifepristone Ruling Makes Drug Development Tricky; Hantavirus Outbreak Shows Risk Of WHO Absence
Editorial writers discuss these public health topics.
By khnelysiag